About
Thomas Ichim is an immunologist and biotechnology executive whose public profile spans regenerative medicine, immunotherapy, stem cells, and translational biotech. Public sources identify him as Chief Scientific Officer of Venvalo Group, while prior filings and press releases show senior operating roles at Medistem, Creative Medical Technology, and Batu Biologics. He also appears in venture-related roles, including Managing Partner of Vendevia Group and founder of Newstar Ventures.
Areas of interest
biotechregenerative medicineimmunotherapycell therapystem cellsoncologytranslational medicinescientific due diligenceventure investing